Edular

News Story

10/05/2009

Meda Pharmaceuticals Inc. announced the commercial availability of EDLUAR™ (zolpidem tartrate sublingual tablets) in the United States. EDLUAR is indicated for the short-term treatment of insomnia characterized by difficulties with falling asleep. EDLUAR is the first available under-the-tongue formulation of zolpidem tartrate, which is the most prescribed treatment for insomnia. Zolpidem tartrate is also the active ingredient in Ambien® oral tablets.More »

Syndicate content